TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Hiku Brands Company Ltd. (“Hiku”) (CSE:HIKU) and
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD”) are pleased to announce
that WeedMD has obtained an interim order from the Ontario Superior Court of Justice authorizing the holding of an annual and
special meeting (the “WeedMD Meeting”) of WeedMD shareholders (“WeedMD
Shareholders”) to consider the previously announced merger (the “Merger Transaction” or the
“Arrangement”) between Hiku and WeedMD.
As described in the joint Hiku and WeedMD press release dated April 19, 2018, WeedMD will be seeking WeedMD
Shareholder approval for the Arrangement under the Business Corporations Act (Ontario) (the “Arrangement
Resolution”). The WeedMD Meeting to consider the Arrangement Resolution will be held on Wednesday, July 11, 2018 at 10:00
a.m. (Toronto time) at Fogler, Rubinoff LLP, located at TD Centre North Tower, Suite 3000, 77 King Street, Toronto, Ontario. WeedMD
Shareholders of record as of the close of business on May 23, 2018 (the “Record Date”) are eligible to vote at the
WeedMD Meeting.
The information circular with respect to the WeedMD Meeting is in the process of being mailed out to the WeedMD
Shareholders and will also be available under WeedMD’s profile on SEDAR at www.sedar.com.
About Hiku Brands
Hiku is focused on building a portfolio of engaging cannabis brands, unsurpassed retail experiences and
handcrafted cannabis production. With a national retail footprint led by Tokyo Smoke, craft cannabis production through DOJA’s
ACMPR (defined below) licensed grow, and Van der Pop’s female-focused educational platforms, Hiku houses an industry-leading
portfolio that aims to set the bar for cannabis brands in Canada.
Hiku’s wholly-owned subsidiary, DOJA Cannabis Ltd., is a federally licensed to cultivate and sell cannabis
pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), owning two production facilities in
the heart of British Columbia’s Okanagan Valley. Hiku’s wholly-owned subsidiary, Tokyo Smoke has been conditionally awarded one of
four master retail licenses in Manitoba. Hiku also operates a network of retail stores selling coffee, clothing and curated
accessories, across British Columbia, Alberta and Ontario.
About WeedMD
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and
distributor of medical cannabis and oils under the ACMPR. The Company operates a 26,000 sq. ft. indoor facility in Aylmer, Ontario,
and a second cultivation site at its greenhouse facility located in Strathroy, Ontario, representing 610,000 sq. ft. or 14 acres
under glass. WeedMD has entered into supply agreements in addition to strategic relationships with established cannabis brands.
WeedMD is focused on providing medical cannabis to the seniors' markets in Canada through its proprietary seniors care program. It
is dedicated to educating healthcare practitioners and furthering public understanding of the role that medical cannabis plays –
including as it pertains to regulatory requirements, indications and potential side effects.
For Further Information, Please Contact:
Will Stewart
Hiku Vice President of Corporate Communications and Public Affairs
416-899-9422
wstewart@hiku.com
Keith Merker
WeedMD CFO
519-706-4900
keith@weedmd.com
Cautionary Statement on Forward-Looking Information
This news release contains forward-looking statements. Forward-looking statements involve known and unknown
risks, uncertainties and other factors which may cause the actual results, performance or achievements of Hiku and WeedMD to be
materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
These forward-looking statements include, but are not limited to, statements relating to our expectations with respect to: the
timing and outcome of the Transaction; the anticipated benefits of the Transaction to the parties and their respective security
holders; impact of the Transaction and anticipated growth of the combined entity, including planned capacity; and the anticipated
timing of the WeedMD Meeting. Often, but not always, forward-looking statements can be identified by the use of words such as
“plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or
“believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”,
“might” or “will” be taken, occur or be achieved. In respect of the forward-looking statements and information concerning the
anticipated benefits and completion of the Transaction and the anticipated timing for completion of the Transaction, Hiku and
WeedMD have provided such statements and information in reliance on certain assumptions that they believe are reasonable at this
time, including assumptions as to the time required to prepare and mail security holder meeting materials; the ability of the
parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholders approvals; the
ability of the parties to satisfy, in a timely manner, the other conditions to the closing of the Transaction; and other
expectations and assumptions concerning the Transaction. There can be no assurance that the Transaction will occur, or that it will
occur on the terms and conditions contemplated in this news release. The Transaction could be modified, restructured or terminated.
Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press
release.
Since forward-looking statements and information address future events and conditions, by their very nature they
involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number
of factors and risks. Readers are cautioned that the foregoing list of factors is not exhaustive. Additional information on other
factors that could affect the operations or financial results of the parties are included in reports on file with applicable
securities regulatory authorities.
The forward-looking statements contained in this news release are made as of the date of this release and,
accordingly, are subject to change after such date. Hiku and WeedMD do not assume any obligation to update or revise any
forward-looking statements, whether written or oral, that may be made from time to time by us or on our behalf, except as required
by applicable law.
None of the TSX Venture Exchange (“TSXV”) or the Canadian Securities Exchange and their
Regulation Services Providers accept responsibility for the adequacy or accuracy of this release.
Completion of the Transaction is subject to a number of conditions, including but not limited to, TSXV
acceptance. The Transaction cannot close until the required WeedMD Shareholder approval is obtained. There can be no assurance that
the Transaction will be completed as proposed or at all.
Investors are cautioned that, except as disclosed in the management information circular to be prepared in
connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or
complete and should not be relied upon. Trading in the securities of WeedMD and Hiku should be considered highly speculative.
The TSXV has in no way passed upon the merits of the proposed transaction and has neither approved nor
disapproved the contents of this news release.
____________________________________________________________________________________________________________________________
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE
